BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17476638)

  • 1. [Prevention of type 2 diabetes mellitus: proven and new aspects].
    Ritzel RA; Isermann B; Woerle HJ
    Dtsch Med Wochenschr; 2007 May; 132(19):1057-61. PubMed ID: 17476638
    [No Abstract]   [Full Text] [Related]  

  • 2. Economics of type 2 diabetes prevention.
    Kissimova-Skarbek K
    Przegl Lek; 2006; 63 Suppl 4():9-11. PubMed ID: 16967708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Are the short-acting insulin analogs superfluous?].
    Arand M
    MMW Fortschr Med; 2006 Mar; 148(11):17. PubMed ID: 16612957
    [No Abstract]   [Full Text] [Related]  

  • 4. [New, expensive antidiabetics for the treatment of type-2 diabetes--pro].
    Müller-Wieland D
    Dtsch Med Wochenschr; 2010 May; 135(18):922. PubMed ID: 20425678
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.
    Levin P
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():66-75. PubMed ID: 18577158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should future health-care costs be discounted? The case of diabetes in Australia.
    Scuffham PA
    Intern Med J; 2006 Mar; 36(3):148-9. PubMed ID: 16503948
    [No Abstract]   [Full Text] [Related]  

  • 7. [Economic evaluation of drugs. Effectiveness in diabetes therapy].
    Schöffski O
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S106-9; discussion S124-6. PubMed ID: 18686218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short acting insulin analogues for type 2 diabetes. Unnecessary additional expenditure or valuable added benefit? Interview by Böhm Sanja].
    Hess R; Kerner W
    Dtsch Med Wochenschr; 2006 Oct; Suppl 1():36-7. PubMed ID: 17595817
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical management of type 2 diabetes in indigenous youth.
    Sellers EA; Moore K; Dean HJ
    Pediatr Clin North Am; 2009 Dec; 56(6):1441-59. PubMed ID: 19962030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of diabetes: a strategic approach for individual patients.
    Shin JA; Lee JH; Kim HS; Choi YH; Cho JH; Yoon KH
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():79-84. PubMed ID: 23280871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity and diabetes mellitus: increasing problems call for increasing efforts].
    Nauck M
    Dtsch Med Wochenschr; 2010 May; 135(18):901. PubMed ID: 20425673
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic models in type 2 diabetes.
    Yi Y; Philips Z; Bergman G; Burslem K
    Curr Med Res Opin; 2010 Sep; 26(9):2105-18. PubMed ID: 20642392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (How) can we prevent type 2 diabetes?
    Buchanan TA
    Diabetes; 2007 Jun; 56(6):1502-7. PubMed ID: 17389328
    [No Abstract]   [Full Text] [Related]  

  • 15. A cost-effectiveness analysis of a community-based diabetes prevention program in Sweden.
    Johansson P; Ostenson CG; Hilding AM; Andersson C; Rehnberg C; Tillgren P
    Int J Technol Assess Health Care; 2009 Jul; 25(3):350-8. PubMed ID: 19619354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current cost analysis in the management of diabetes mellitus].
    Oberender P
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S110-4; discussion S124-6. PubMed ID: 18686219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trends in treating type 2 diabetes.
    Hollander PA
    Postgrad Med; 2000 May; 107(6 Suppl Key):4-10. PubMed ID: 19667504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of type 2 diabetes.
    American Association of Diabetes Educators
    Diabetes Educ; 2012; 38(1):147-50. PubMed ID: 22328043
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary prevention of type 2 diabetes: how do we do it?
    Abdul-Ghani MA; Sabah M; Minuchin O; Vardi P; Raz I; Wainstein J
    Isr Med Assoc J; 2004 May; 6(5):305-7. PubMed ID: 15151376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.